Verapamil Hydrochloride
Verapamil Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Verapamil Hydrochloride; Generic name: VERAPAMIL HYDROCHLORIDE; Manufacturer: Teva Pharmaceuticals Inc.
| Brand name | Verapamil Hydrochloride |
|---|---|
| Generic name | VERAPAMIL HYDROCHLORIDE |
| Manufacturer | Teva Pharmaceuticals Inc |
| Used for | INDICATIONS AND USAGE Verapamil hydrochloride sustained-release capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one |
| Dosage | DOSAGE AND ADMINISTRATION Essential Hypertension The dose of verapamil hydrochloride sustained-release capsules should be individualized by titration. The usual daily dose of sustained-release verapamil, verapamil hydrochloride sustained-release capsules, in clinical trials has been 240 mg given by mouth once daily in the morning. However, initial doses of 120 mg a day may be warranted in patients who may have an increased response to verapamil (e.g., elderly, small people, etc.). Upward titrati |
| Warnings | WARNINGS Heart Failure Verapamil has a negative inotropic effect which, in most patients, is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net impairment of ventricular performance. In clinical experience with 4,954 patients, 87 (1.8%) developed congestive heart failure or pulmonary edema. Verapamil should be avoided in patients with severe left ventricular dysfunction (e.g., ejection fraction less than 30% or moderate to severe symptoms of |
| Active ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0742cf97-601b-4c13-a6c3-1a6a616ed292 |